If you appreciate the content here, please consider giving posts a like and share. It's a simple gesture that doesn't cost a thing, but it goes a long way in promoting posts, spreading the content, and bringing awareness and understanding to others who might benefit. You are awesome. Be awesome.
IPAK-EDU Director’s Science Webinar
Monday 7/29 @ 7:00pm Eastern
with/ Maria Gutschi
“modRNA COVID-19 Vaccines: A Regulatory and Manufacturing Failed Experiment”
Maria will talk about how the regulatory standards were lowered for the EMA, FDA and Health Canada but were continued to be promoted as ‘safe and effective.’
She will also discuss how these experimental products were likely the most complicated products ever developed and manufactured, how gene therapy safeguards were not applied, how contamination with DNA and dsRNA show adulteration, misrepresentation and nondisclosure, how the LNPs were not assessed or tested appropriately and how the analytical tests were insufficient and not fit for purpose.
Finally, she will talk about what risks have been confirmed from the manufacturing process and their potential effects on human health.
Register by clicking the button below!
Please note: registration closes at 5pm Eastern, on the day of the webinar.
Late registrants will receive access to the full recording, but may not receive the link to the live session in time. Thank you for your understanding.
Registrants get access to the live talk and a recording of the session!
Webinar subscribers get the bonus of access to a ever-growing catalog of past webinar session recordings — subscribe now, it’s worth it!
If you like what you see, and you’re willing and able, consider leaving a tip. Every little bit helps. Thank you!
Once a week, this webinar series brings a focus to science as it applies to public issues of concern. The webinar brings to you expertise from scientists, researchers, data analysts, medical professionals, health advocates, attorneys, and more, all with the opportunity to learn, ask questions, and hear directly from people working at the leading edge.
Join us!